143 related articles for article (PubMed ID: 10928647)
1. Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.
Warnick GR
Clin Chem Lab Med; 2000 Apr; 38(4):287-300. PubMed ID: 10928647
[TBL] [Abstract][Full Text] [Related]
2. Quality of lipid and lipoprotein measurements in community laboratories.
Watson JE; Evans RW; Germanowski J; Caggiula AW; Olson MB; Hauth BA
Arch Pathol Lab Med; 1997 Feb; 121(2):105-9. PubMed ID: 9126034
[TBL] [Abstract][Full Text] [Related]
3. Laboratory measurement of lipid and lipoprotein risk factors.
Warnick GR
Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
[TBL] [Abstract][Full Text] [Related]
4. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
Grafnetter D; Feruglio GA; Vanuzzo D
G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
[TBL] [Abstract][Full Text] [Related]
5. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study.
Magnussen CG; Raitakari OT; Thomson R; Juonala M; Patel DA; Viikari JS; Marniemi J; Srinivasan SR; Berenson GS; Dwyer T; Venn A
Circulation; 2008 Jan; 117(1):32-42. PubMed ID: 18071074
[TBL] [Abstract][Full Text] [Related]
6. Measurement of cholesterol in plasma and other body fluids.
Warnick GR; Remaley AT
Curr Atheroscler Rep; 2001 Sep; 3(5):404-11. PubMed ID: 11565569
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of two compact analyzers used for lipid analysis.
McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
[TBL] [Abstract][Full Text] [Related]
9. Traditional lipoprotein profile: clinical utility, performance requirement, and standardization.
Myers GL; Cooper GR; Sampson EJ
Atherosclerosis; 1994 Aug; 108 Suppl():S157-69. PubMed ID: 7802722
[TBL] [Abstract][Full Text] [Related]
10. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions.
McNamara JR; Schaefer EJ
Clin Chim Acta; 1987 Jun; 166(1):1-8. PubMed ID: 3608193
[TBL] [Abstract][Full Text] [Related]
11. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.
Myers GL; Cooper GR; Winn CL; Smith SJ
Clin Lab Med; 1989 Mar; 9(1):105-35. PubMed ID: 2538292
[TBL] [Abstract][Full Text] [Related]
12. Laboratory standardization of a large international clinical trial: the DAIS experience. DAIS Project Group. Diabetes Atherosclerosis Intervention Study.
McGuinness C; Seccombe DW; Frohlich JJ; Ehnholm C; Sundvall J; Steiner G
Clin Biochem; 2000 Feb; 33(1):15-24. PubMed ID: 10693982
[TBL] [Abstract][Full Text] [Related]
13. Progress in blood lipid reporting practices by clinical laboratories in North America. Changes from 1985 to 1990.
Engel JA; Petersen EC; Wilson JE; McManus BM
Arch Pathol Lab Med; 1992 Mar; 116(3):229-34. PubMed ID: 1536606
[TBL] [Abstract][Full Text] [Related]
14. Ten-year evaluation of homogeneous low-density lipoprotein cholesterol methods developed by Japanese manufacturers. Application of the Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization protocol.
Nakamura M; Koyama I; Iso H; Sato S; Okazaki M; Kayamori Y; Kiyama M; Kitamura A; Shimamoto T; Ishikawa Y
J Atheroscler Thromb; 2010 Dec; 17(12):1275-81. PubMed ID: 20885070
[TBL] [Abstract][Full Text] [Related]
15. Measurement performance of reagent manufacturers by Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization specified for metabolic syndrome-focused health checkups program in Japan.
Nakamura M; Koyama I; Iso H; Sato S; Okazaki M; Kiyama M; Shimamoto T; Konishi M
J Atheroscler Thromb; 2009; 16(6):756-63. PubMed ID: 19763016
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
17. Progress in lipid reporting practices and reliability of blood cholesterol measurement in clinical laboratories in Nebraska. Efforts to align results with the Centers for Disease Control, and feasibility of meeting National Cholesterol Education Program Guidelines.
McManus BM; Toth AB; Engel JA; Myers GL; Naito HK; Wilson JE; Cooper GR
JAMA; 1989 Jul; 262(1):83-8. PubMed ID: 2543838
[TBL] [Abstract][Full Text] [Related]
18. Standardization of lipoprotein reporting.
Kroll MH; Cole TG; Rifai N; Cooper G; Warnick GR; Jialal I
Am J Clin Pathol; 2000 Nov; 114(5):696-702. PubMed ID: 11068542
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein profile in physiological pregnancy.
Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
[TBL] [Abstract][Full Text] [Related]
20. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
Bookstein L; Gidding SS; Donovan M; Smith FA
Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
